ID
INVG
Investing
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.
The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.
The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.
The company will use the funds to bring its disease management platform to more markets.
It offers end-to-end, AI-driven digital ecosystem solutions for hospitals and insurers.
It offers end-to-end, AI-driven digital ecosystem solutions for hospitals and insurers.
Epicore Biosystems expands Series B to $32 million to advance sweat-sensing wearable technology.
Epicore Biosystems expands Series B to $32 million to advance sweat-sensing wearable technology.
Aktiia announced an oversubscribed $42 million Series B round, and Basil Systems secured $11.5 million in funding.